Viewing Study NCT05831969


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2025-12-25 @ 8:17 PM
Study NCT ID: NCT05831969
Status: UNKNOWN
Last Update Posted: 2023-04-26
First Post: 2023-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC
Sponsor: Shenyang Tenth People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module